Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Management of E. coli sister chromatid cohesion in response to genotoxic stress.

Vickridge E, Planchenault C, Cockram C, Junceda IG, Espéli O.

Nat Commun. 2017 Mar 6;8:14618. doi: 10.1038/ncomms14618.

2.

Cataloging antineoplastic agents according to their effectiveness against platinum-resistant and platinum-sensitive ovarian carcinoma cell lines.

Ishiguro K, Zhu YL, Lin ZP, Penketh PG, Shyam K, Zhu R, Baumann RP, Sartorelli AC, Rutherford TJ, Ratner ES.

J Transl Sci. 2016;2(2):117-124. Epub 2016 Mar 5.

3.

Triapine potentiates platinum-based combination therapy by disruption of homologous recombination repair.

Ratner ES, Zhu YL, Penketh PG, Berenblum J, Whicker ME, Huang PH, Lee Y, Ishiguro K, Zhu R, Sartorelli AC, Lin ZP.

Br J Cancer. 2016 Mar 29;114(7):777-86. doi: 10.1038/bjc.2016.54. Epub 2016 Mar 10.

4.

DNA Mismatch Repair.

Marinus MG.

EcoSal Plus. 2012 Nov;5(1). doi: 10.1128/ecosalplus.7.2.5.

5.

Towards an informative mutant phenotype for every bacterial gene.

Deutschbauer A, Price MN, Wetmore KM, Tarjan DR, Xu Z, Shao W, Leon D, Arkin AP, Skerker JM.

J Bacteriol. 2014 Oct;196(20):3643-55. doi: 10.1128/JB.01836-14. Epub 2014 Aug 11.

6.

MutS Homologues hMSH4 and hMSH5: Genetic Variations, Functions, and Implications in Human Diseases.

Clark N, Wu X, Her C.

Curr Genomics. 2013 Apr;14(2):81-90. doi: 10.2174/1389202911314020002.

7.

Rad51 expression is a useful predictive factor for the efficacy of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the esophagus.

Nakanoko T, Saeki H, Morita M, Nakashima Y, Ando K, Oki E, Ohga T, Kakeji Y, Toh Y, Maehara Y.

Ann Surg Oncol. 2014 Feb;21(2):597-604. doi: 10.1245/s10434-013-3220-2. Epub 2013 Sep 25. Erratum in: Ann Surg Oncol. 2014 Dec;21 Suppl 4;S776.

8.

Poly (ADP-ribose) polymerase inhibitors: on the horizon of tailored and personalized therapies for epithelial ovarian cancer.

Ratner ES, Sartorelli AC, Lin ZP.

Curr Opin Oncol. 2012 Sep;24(5):564-71. doi: 10.1097/CCO.0b013e3283564230. Review.

9.

Bleomycin sensitivity in Escherichia coli is medium-dependent.

Xu T, Brown W, Marinus MG.

PLoS One. 2012;7(3):e33256. doi: 10.1371/journal.pone.0033256. Epub 2012 Mar 15.

10.

Reduced level of ribonucleotide reductase R2 subunits increases dependence on homologous recombination repair of cisplatin-induced DNA damage.

Lin ZP, Lee Y, Lin F, Belcourt MF, Li P, Cory JG, Glazer PM, Sartorelli AC.

Mol Pharmacol. 2011 Dec;80(6):1000-12. doi: 10.1124/mol.111.074708. Epub 2011 Aug 29.

11.

The expression of ERCC1, RRM1, and BRCA1 in breast cancer according to the immunohistochemical phenotypes.

Kim D, Jung W, Koo JS.

J Korean Med Sci. 2011 Mar;26(3):352-9. doi: 10.3346/jkms.2011.26.3.352. Epub 2011 Feb 25.

12.

A dual function of the CRISPR-Cas system in bacterial antivirus immunity and DNA repair.

Babu M, Beloglazova N, Flick R, Graham C, Skarina T, Nocek B, Gagarinova A, Pogoutse O, Brown G, Binkowski A, Phanse S, Joachimiak A, Koonin EV, Savchenko A, Emili A, Greenblatt J, Edwards AM, Yakunin AF.

Mol Microbiol. 2011 Jan;79(2):484-502. doi: 10.1111/j.1365-2958.2010.07465.x. Epub 2010 Dec 7.

13.

Determination of hypersensitivity to genotoxic agents among Escherichia coli single gene knockout mutants.

Becket E, Chen F, Tamae C, Miller JH.

DNA Repair (Amst). 2010 Sep 4;9(9):949-57. doi: 10.1016/j.dnarep.2010.06.008. Epub 2010 Jul 31.

14.

Photoaffinity isolation and identification of proteins in cancer cell extracts that bind to platinum-modified DNA.

Guggenheim ER, Xu D, Zhang CX, Chang PV, Lippard SJ.

Chembiochem. 2009 Jan 5;10(1):141-57. doi: 10.1002/cbic.200800471.

15.

Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells.

Rink L, Slupianek A, Stoklosa T, Nieborowska-Skorska M, Urbanska K, Seferynska I, Reiss K, Skorski T.

Blood. 2007 Jul 15;110(2):651-60. Epub 2007 Apr 12.

16.

Differential effects of cisplatin and MNNG on dna mutants of Escherichia coli.

Calmann MA, Marinus MG.

Mutat Res. 2005 Oct 15;578(1-2):406-16.

17.

MutS inhibits RecA-mediated strand transfer with methylated DNA substrates.

Calmann MA, Evans JE, Marinus MG.

Nucleic Acids Res. 2005 Jun 22;33(11):3591-7. Print 2005.

18.

MutS inhibits RecA-mediated strand exchange with platinated DNA substrates.

Calmann MA, Marinus MG.

Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14174-9. Epub 2004 Sep 16.

19.

Cell-interdependent cisplatin killing by Ku/DNA-dependent protein kinase signaling transduced through gap junctions.

Jensen R, Glazer PM.

Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6134-9. Epub 2004 Apr 6.

20.

Supplemental Content

Support Center